PARP1 and hematopoietic and lymphoid system neoplasm: Therefore, in this study, we examined whether PARP inhibitors enhance cytotoxicity against human tumor cells of blood cancer and colon cancers in combination with the DNA demethylating agent 5-aza-dC.